164 related articles for article (PubMed ID: 37452172)
21. The tumor immune microenvironment and immune-related signature predict the chemotherapy response in patients with osteosarcoma.
He L; Yang H; Huang J
BMC Cancer; 2021 May; 21(1):581. PubMed ID: 34016089
[TBL] [Abstract][Full Text] [Related]
22. Molecular characterization of Golgi apparatus-related genes indicates prognosis and immune infiltration in osteosarcoma.
Zhang J; Liu J; Ding R; Miao X; Deng J; Zhao X; Wu T; Cheng X
Aging (Albany NY); 2024 Mar; 16(6):5249-5263. PubMed ID: 38460960
[TBL] [Abstract][Full Text] [Related]
23. Signature constructed by glycolysis-immune-related genes can predict the prognosis of osteosarcoma patients.
Tian K; Qi W; Yan Q; Lv M; Song D
Invest New Drugs; 2022 Aug; 40(4):818-830. PubMed ID: 35435626
[TBL] [Abstract][Full Text] [Related]
24. Molecular characterization of immunogenic cell death indicates prognosis and tumor microenvironment infiltration in osteosarcoma.
Liu Z; Liu B; Feng C; Li C; Wang H; Zhang H; Liu P; Li Z; He S; Tu C
Front Immunol; 2022; 13():1071636. PubMed ID: 36569869
[TBL] [Abstract][Full Text] [Related]
25. C-C Motif Chemokine Ligand 5 (CCL5): A Potential Biomarker and Immunotherapy Target for Osteosarcoma.
Zheng H; Wang Y; Li F
Curr Cancer Drug Targets; 2024; 24(3):308-318. PubMed ID: 37581517
[TBL] [Abstract][Full Text] [Related]
26. 12 Survival-related differentially expressed genes based on the TARGET-osteosarcoma database.
Rothzerg E; Xu J; Wood D; Kõks S
Exp Biol Med (Maywood); 2021 Oct; 246(19):2072-2081. PubMed ID: 33926256
[TBL] [Abstract][Full Text] [Related]
27. TYROBP, TLR4 and ITGAM regulated macrophages polarization and immune checkpoints expression in osteosarcoma.
Liang T; Chen J; Xu G; Zhang Z; Xue J; Zeng H; Jiang J; Chen T; Qin Z; Li H; Ye Z; Nie Y; Liu C; Zhan X
Sci Rep; 2021 Sep; 11(1):19315. PubMed ID: 34588497
[TBL] [Abstract][Full Text] [Related]
28. Comprehensive analysis of a glycolysis and cholesterol synthesis-related genes signature for predicting prognosis and immune landscape in osteosarcoma.
Xu F; Yan J; Peng Z; Liu J; Li Z
Front Immunol; 2022; 13():1096009. PubMed ID: 36618348
[TBL] [Abstract][Full Text] [Related]
29. Single-Cell RNA Sequencing Pro-angiogenic Macrophage Profiles Reveal Novel Prognostic Biomarkers and Therapeutic Targets for Osteosarcoma.
Yi C; Li Z; Zhao Q; Gong D; Zhao S; Chen Z; Cheng C; Bian E; Tian D
Biochem Genet; 2024 Apr; 62(2):1325-1346. PubMed ID: 37603193
[TBL] [Abstract][Full Text] [Related]
30. Characterization of the Tumor Microenvironment in Osteosarcoma Identifies Prognostic- and Immunotherapy-Relevant Gene Signatures.
Tan J; Feng X; Wu H; Yang B; Shi M; Xie C; Su Z; Li L; Luo M; Zuo Z; Zhu S; Yang J; Lin L
J Immunol Res; 2022; 2022():6568278. PubMed ID: 36065454
[TBL] [Abstract][Full Text] [Related]
31. Identification of Hypoxia-Related Subtypes, Establishment of Prognostic Models, and Characteristics of Tumor Microenvironment Infiltration in Colon Cancer.
Wang C; Tang Y; Ma H; Wei S; Hu X; Zhao L; Wang G
Front Genet; 2022; 13():919389. PubMed ID: 35783281
[No Abstract] [Full Text] [Related]
32. The prognostic value and immune landscapes of m1A/m5C/m6A-associated lncRNA signature in osteosarcoma.
Wu ZY; Shi ZY
Eur Rev Med Pharmacol Sci; 2022 Aug; 26(16):5868-5883. PubMed ID: 36066162
[TBL] [Abstract][Full Text] [Related]
33. Anoikis patterns exhibit distinct prognostic and immune landscapes in Osteosarcoma.
Zhang Z; Zhu Z; Fu J; Liu X; Mi Z; Tao H; Fan H
Int Immunopharmacol; 2023 Feb; 115():109684. PubMed ID: 36630752
[TBL] [Abstract][Full Text] [Related]
34. Identification and verification of a BMPs-related gene signature for osteosarcoma prognosis prediction.
Xie L; Zeng J; He M
BMC Cancer; 2023 Feb; 23(1):181. PubMed ID: 36814224
[TBL] [Abstract][Full Text] [Related]
35. A novel risk score model based on eight genes and a nomogram for predicting overall survival of patients with osteosarcoma.
Wu G; Zhang M
BMC Cancer; 2020 May; 20(1):456. PubMed ID: 32448271
[TBL] [Abstract][Full Text] [Related]
36. A tumor microenvironment-based prognostic index for osteosarcoma.
Wu C; Gong S; Duan Y; Deng C; Kallendrusch S; Berninghausen L; Osterhoff G; Schopow N
J Biomed Sci; 2023 Apr; 30(1):23. PubMed ID: 37055822
[TBL] [Abstract][Full Text] [Related]
37. Immunogenic cell death related mRNAs associated signature to predict immunotherapeutic response in osteosarcoma.
Han S; Wang Q; Shen M; Zhang X; Wang J
Heliyon; 2024 Mar; 10(6):e27630. PubMed ID: 38515694
[TBL] [Abstract][Full Text] [Related]
38. Exploring the relationship between metabolism and immune microenvironment in osteosarcoma based on metabolic pathways.
Wu C; Tan J; Shen H; Deng C; Kleber C; Osterhoff G; Schopow N
J Biomed Sci; 2024 Jan; 31(1):4. PubMed ID: 38212768
[TBL] [Abstract][Full Text] [Related]
39. Vessel state and immune infiltration of the angiogenesis subgroup and construction of a prediction model in osteosarcoma.
Wu J; Jin Z; Lin J; Fu Y; Wang J; Shen Y
Front Immunol; 2022; 13():992266. PubMed ID: 36405691
[TBL] [Abstract][Full Text] [Related]
40. Exploration of Immune-Related Gene Expression in Osteosarcoma and Association With Outcomes.
Liu W; Xie X; Qi Y; Wu J
JAMA Netw Open; 2021 Aug; 4(8):e2119132. PubMed ID: 34342651
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
